GP100110: Arg8-CGSG-MUC1(137-156)-Tn(144) Pack Size:0.5 mg N-α-Fmoc-O-β-(tri-O-acetyl-β-L-fucopyranosyl)-L-serine

N-α-Fmoc-O-β-(tri-O-acetyl-β-L-fucopyranosyl)-L-serine

72 / IgA1 synthetic Hinge Region peptide fragment from Val222 to Cys241 with glycosylation (α-GalNAc) at Thr228

/ Fmoc-Asn(Fucα(1-6)GlcNAc)-OH (Peracetate) / Fucosylated GlcNAc Core Asparagine (Fmoc

followed by cleavage of the α-glycosidic bond by α-L-iduronidase (IDUA) to release 4-methylumbelliferone

GP100110: Arg8-CGSG-MUC1(137-156)-Tn(144) Pack Size:0.5 mg N-α-Fmoc-O-β-(tri-O-acetyl-β-L-fucopyranosyl)-L-serineC146H253N63O45S 3643. 03 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Gly137 His156; UniProt position 137 156, aa length 20) from the variable number tandem repeat (TR) domain. The fragment contains tumour associated carbohydrate antigen (TACA), Tn (GalNAc O Thr) at Thr144. Arg8 is conjugated at N terminal. Arg8 is separated from the MUC1 sequence by Cys Gly Ser Gly. The C terminus is an amide. Arg8 CGSG MUC1(137 156) Tn(144) Mucin1; R8